Literature DB >> 31648318

Association between the HLA-DRB1*03:01-DQB1*02:01 haplotype and PF4/heparin antibodies.

Ray Zhang1, Brian F Duffy2, Vinzenz Lange3, Charles S Eby1,4, Chang Liu1.   

Abstract

Entities:  

Year:  2019        PMID： 31648318      PMCID： PMC6849947          DOI： 10.1182/bloodadvances.2019000311

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  22 in total

1.  Anti-heparin-platelet factor 4 antibodies after cardiopulmonary bypass: role of HLA expression.

Authors:  D Paparella; M Micelli; B Favoino; M D'Alò; T Fiore; L de Luca Tupputi Schinosa
Journal:  Haematologica       Date:  2001-03       Impact factor: 9.941

2.  Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels.

Authors:  Steven Baroletti; Shelley Hurwitz; Nicole A S Conti; John Fanikos; Gregory Piazza; Samuel Z Goldhaber
Journal:  Am J Med       Date:  2011-11-08       Impact factor: 4.965

3.  Localization of central MHC genes influencing type I diabetes.

Authors:  K Y Cheong; R J Allcock; P Eerligh; C S Witt; F T Christiansen; V McCann; P Price
Journal:  Hum Immunol       Date:  2001-12       Impact factor: 2.850

4.  Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.

Authors:  T E Warkentin; A Greinacher; Y Gruel; R H Aster; B H Chong
Journal:  J Thromb Haemost       Date:  2011-12       Impact factor: 5.824

Review 5.  Heparin-Induced Thrombocytopenia in Cardiac Surgery Patients.

Authors:  Allyson M Pishko; Adam Cuker
Journal:  Semin Thromb Hemost       Date:  2017-06-08       Impact factor: 4.180

6.  Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis.

Authors:  Francesca Menconi; Roman Osman; Maria C Monti; David A Greenberg; Erlinda S Concepcion; Yaron Tomer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

7.  Identification of T cells responding to a self-protein modified by an external agent.

Authors:  S Bacsi; R Geoffrey; G Visentin; R De Palma; R Aster; J Gorski
Journal:  Hum Immunol       Date:  2001-02       Impact factor: 2.850

8.  Correlation of ELISA optical density with clinical diagnosis of heparin-induced thrombocytopenia: a retrospective study of 104 patients with positive anti-PF4/heparin ELISA.

Authors:  Marc-André Pearson; Chantal Nadeau; Normand Blais
Journal:  Clin Appl Thromb Hemost       Date:  2013-11-27       Impact factor: 2.389

9.  Improving clinical interpretation of the anti-platelet factor 4/heparin enzyme-linked immunosorbent assay for the diagnosis of heparin-induced thrombocytopenia through the use of receiver operating characteristic analysis, stratum-specific likelihood ratios, and Bayes theorem.

Authors:  Robert A Raschke; Steven C Curry; Theodore E Warkentin; Richard D Gerkin
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

10.  Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism.

Authors:  Christine G Parks; Janardan P Pandey; Mary Anne Dooley; Edward L Treadwell; E W St Clair; Gary S Gilkeson; Carol A Feghali-Bostwick; Carol L Feghali-Botswick; Glinda S Cooper
Journal:  Hum Immunol       Date:  2004-06       Impact factor: 2.850
View more
  5 in total

Review 1.  Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies.

Authors:  Mohitosh Biswas; Nares Sawajan; Thanyada Rungrotmongkol; Kamonpan Sanachai; Maliheh Ershadian; Chonlaphat Sukasem
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

Review 2.  Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS.

Authors:  Emmanuel J Favaloro; Leonardo Pasalic; Giuseppe Lippi
Journal:  Antibodies (Basel)       Date:  2022-01-21

Review 3.  Elucidation of Cellular Contributions to Heparin-Induced Thrombocytopenia Using Omic Approaches.

Authors:  Jason B Giles; Elise C Miller; Heidi E Steiner; Jason H Karnes
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

4.  Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia.

Authors:  Jason B Giles; Heidi E Steiner; Jerome Rollin; Christian M Shaffer; Yukihide Momozawa; Taisei Mushiroda; Chihiro Inai; Kathleen Selleng; Thomas Thiele; Claire Pouplard; Nancy M Heddle; Michiaki Kubo; Elise C Miller; Kiana L Martinez; Elizabeth J Phillips; Theodore E Warkentin; Yves Gruel; Andreas Greinacher; Dan M Roden; Jason H Karnes
Journal:  Blood Adv       Date:  2022-07-26

5.  Ancient DNA Study in Medieval Europeans Shows an Association Between HLA-DRB1*03 and Paratyphoid Fever.

Authors:  Magdalena Haller; Joanna H Bonczarowska; Dirk Rieger; Tobias L Lenz; Almut Nebel; Ben Krause-Kyora
Journal:  Front Immunol       Date:  2021-07-15       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.